化合物HPGDS-IN-1
|
|
|
- CAS号:
- 1234708-04-3
- 英文名:
- N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide
- 英文别名:
- CS-1754;EOS-61636;SAR191801;hPGDS-IN-1;hPGDS-IN-1, 10 mM in DMSO;Inhibitor,inhibit,hPGDS IN 1,Prostaglandin E synthase,hPGDSIN1,PGE synthase;N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide;2-(pyridin-2-yl)pyriMidine-5-carboxylic acid 3-[5-(1-hydroxy-1-Methylethyl)-1,2,4]oxadiazol-3-yl-benzylaMide;N-({3-[5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-2-(pyridin-2-yl)pyrimidine-5-carboxamide;N-[[3-[5-(1-Hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-(2-pyridinyl)-5-pyrimidinecarboxamide
- 中文名:
- 化合物HPGDS-IN-1
- 中文别名:
- 化合物HPGDS-IN-1;化合物HPGDS-IN-1,10 MM DMSO 溶液;N-(3-(5-(2-羟基丙-2-基)-1,2,4-恶二唑-3-基)苄基)-2-(吡啶-2-基)嘧啶-5-甲酰胺;N-[[3-[5-(1-羟基-1-甲基乙基)-1,2,4-恶二唑-3-基]苯基]甲基]-2-(2-吡啶基)-5-嘧啶甲酰胺
- CBNumber:
- CB22728908
- 分子式:
- C22H20N6O3
- 分子量:
- 416.43
- MOL File:
- 1234708-04-3.mol
|
|
|
化合物HPGDS-IN-1化学性质
-
密度:
-
1.310±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
≥ 20.6mg/mL in DMSO
-
|
-
形态:
-
Solid
-
|
-
酸度系数(pKa):
-
12.34±0.46(Predicted)
-
|
-
颜色:
-
White to off-white
-
|
化合物HPGDS-IN-1性质、用途与生产工艺
hPGDS-IN-1是一种hPGDS抑制剂, 荧光偏振检测或EIA法测得IC50值为12 nM。
化合物HPGDS-IN-1
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2025/02/08 | HY-12791 | 化合物HPGDS-IN-1
hPGDS-IN-1 | 1234708-04-3 | 1 mg | 900元 |
| 2025/02/08 | HY-12791 | 化合物HPGDS-IN-1
hPGDS-IN-1 | 1234708-04-3 | 5mg | 2000元 |
1234708-04-3, 化合物HPGDS-IN-1 相关搜索:
- Inhibitors
- 抑制剂
- 小分子抑制剂，天然产物
- 小分子抑制剂
- 化合物HPGDS-IN-1,10 MM DMSO 溶液
- N-(3-(5-(2-羟基丙-2-基)-1,2,4-恶二唑-3-基)苄基)-2-(吡啶-2-基)嘧啶-5-甲酰胺
- 化合物HPGDS-IN-1
- N-[[3-[5-(1-羟基-1-甲基乙基)-1,2,4-恶二唑-3-基]苯基]甲基]-2-(2-吡啶基)-5-嘧啶甲酰胺
- 1234708-04-3
- hPGDS-IN-1, 10 mM in DMSO
- N-({3-[5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-2-(pyridin-2-yl)pyrimidine-5-carboxamide
- 5-Pyrimidinecarboxamide, N-[[3-[5-(1-hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-(2-pyridinyl)-
- Inhibitor,inhibit,hPGDS IN 1,Prostaglandin E synthase,hPGDSIN1,PGE synthase
- CS-1754
- EOS-61636
- N-[[3-[5-(1-Hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-(2-pyridinyl)-5-pyrimidinecarboxamide
- SAR191801,2-Pyridin-2-yl-pyrimidine-5-carboxylic acid 3-[5-(1-hydroxy-1-methyl-ethyl)-[1,2,4]oxadiazol-3-yl]-benzylamide
- hPGDS-IN-1
- tert-butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane SAR191801
- SAR191801
- 2-(pyridin-2-yl)pyriMidine-5-carboxylic acid 3-[5-(1-hydroxy-1-Methylethyl)-1,2,4]oxadiazol-3-yl-benzylaMide
- N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide